The ROE as of November 2024 (TTM) for Mydecine Innovations Group Inc. (MYCOF) is 206.18%

According to Mydecine Innovations Group Inc.’s latest financial reports and current stock price. The company's current ROE is 206.18%. This represents a change of 198.67% compared to the average of 69.03% of the last 4 quarters.

Mydecine Innovations Group Inc. (MYCOF) Historical ROE (quarterly & annually)

How has MYCOF ROE performed in the past?

The mean historical ROE of Mydecine Innovations Group Inc. over the last ten years is -1453.54%. The current 206.18% ROE has changed -114.18% with respect to the historical average. Over the past ten years (40 quarters), MYCOF's ROE was at its highest in in the December 2015 quarter at 739.45%. The ROE was at its lowest in in the December 2021 quarter at -5149.18%.

Mydecine Innovations Group Inc. (MYCOF) ROE by Quarter and Year

Discovering the peaks and valleys of Mydecine Innovations Group Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mydecine Innovations Group Inc. (MYCOF) Average ROE

How has MYCOF ROE performed in the past?

The current ROE of Mydecine Innovations Group Inc. (MYCOF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Mydecine Innovations Group Inc. (MYCOF) ROE vs. Peers

How is MYCOF’s ROE compared to its peers?

Mydecine Innovations Group Inc.’s ROE is less than Green Cures & Botanical Distribution Inc. (89.83%), greater than Cann American Corp. (-80.83%), less than Rimrock Gold Corp. (8.44%), greater than Galexxy Holdings, Inc. (-150.41%), less than Indoor Harvest Corp (705.60%), less than CBD Global Sciences Inc. (105.36%), greater than MGC Pharmaceuticals Limited (-103.71%), less than Target Group Inc. (3.20%), less than Aequus Pharmaceuticals Inc. (50.78%), greater than Filament Health Corp. (-178.95%), less than Aleafia Health Inc. (965.68%), less than Pharmagreen Biotech Inc. (18.07%), less than Endexx Corporation (22.78%), greater than Green Growth Brands Inc. (-311.96%), less than HempAmericana, Inc (0%), greater than Radient Technologies Inc. (0%), greater than Nextleaf Solutions Ltd. (0%), greater than Abattis Bioceuticals Corp. (-18.36%), greater than null (-26.96%),

Build a custom stock screener for Mydecine Innovations Group Inc. (MYCOF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mydecine Innovations Group Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mydecine Innovations Group Inc. (MYCOF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mydecine Innovations Group Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.